研究报告 |
|
|
|
|
hTERT重组第三代慢病毒载体的构建及其病毒包装鉴定 |
钟艳平1, 林若芸2, 黎丹戎3, 胡晓霞4, 王琪1, 李力1 |
1. 广西医科大学医学科学实验中心 南宁 530021;
2. 广西壮族自治区妇幼保健院生殖中心 南宁 530003;
3. 广西医科大学附属肿瘤医院 南宁 530021;
4. 广西区人民医院 南宁 530021 |
|
Construction of Recombinant Telomerase Reverse Transcriptase Gene Lentiviral Expression Vector and Virus Packaging |
ZHONG Yan-ping1, LIN Ruo-yun2, LI Dan-rong3, HU Xiao-xia4, WANG Qi1, LI Li1 |
1. Medical Scientific Research Center, Guangxi Medical University, Nanning 530021, China;
2. The Assisted Reproduction Centre of Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning 530003, China;
3. Tumor Hospital Affiliated to Guangxi Medical University, Nanning 530021, China;
4. Guangxi Zhuang Autonomous Region People's Hospital, Nanning 530021, China |
引用本文:
钟艳平, 林若芸, 黎丹戎, 胡晓霞, 王琪, 李力. hTERT重组第三代慢病毒载体的构建及其病毒包装鉴定[J]. 中国生物工程杂志, 2011, 31(9): 21-27.
ZHONG Yan-ping, LIN Ruo-yun, LI Dan-rong, HU Xiao-xia, WANG Qi, LI Li. Construction of Recombinant Telomerase Reverse Transcriptase Gene Lentiviral Expression Vector and Virus Packaging. China Biotechnology, 2011, 31(9): 21-27.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/
或
https://manu60.magtech.com.cn/biotech/CN/Y2011/V31/I9/21
|
[1] Betts D H, Perrault S D, Petrik J, et al. Telomere length analysis in goat clones and their offspring.Mol Reprod Dev,2005, 72(4):461-470.
[2] Stampfer M R, Yaswen P.Human epithelial cell immortalization as a step in carcinogenesis.Cancer Letters,2003,194(2):199-208.
[3] Fiedler W,Reinicke D,Aurich H,et al.In vitro immortalisation of porcine hepatocytes by transfection with the gene for the human catalytic subunit of telomerase reverse transcriptase(hTERT).Journal of Hepatology,2004,40(1):102-109.
[4] Naldini L,Blomer U, Gallay P, et al.In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science,1996,272 (5259):263-267.
[5] 郭淑君,万艳,李丽玲,等. FGFR2Ⅲc重组慢病毒载体的构建及其在肌原细胞L6中的表达. 中国生物工程杂志,2011,31(5):1-7 Guo S J,Wan Y,Li L L,et al.China Biotechnology,2011,31(5):1-7.
[6] Kafaie J, Song R, Abrahamyan L, et al. Mapping of nucleocapsid residues important for HIV-1 genomic RNA dimerization and packaging.Virology,2008,375(2):592-610.
[7] LaBarre D D, Lowy R J.Improvements in methods for calculating virus titer estimates from TCID50 and plaque assays.J Virol Methods,2001,96(2):107-126.
[8] Nauta J J, de Bruijn I A. On the bias in HIV titers and how to reduce it. Vaccine,2006,24(46):6645-6646.
[9] 林若芸,黎丹戎,钟艳平,等. 过表达人端粒酶逆转录酶促进人脐静脉血管内皮细胞增殖.中国生物化学与分子生物学报,2011,27(1): 84-89. Lin R Y,Li D R, Zhong Y P,et al.Chinese Journal of Biochemistry and Molecular Biology, 2011,27(1): 84-89.
[10] Kim N W, Piatyszek M A, Prowse K R, et al.Specific association of human telomerase activity with immortal cells and cancer. Science,1994,266(5193):2011-2015.
[11] Stampfer M R, Yaswen P. Human epithelial cell immortalization as a step in carcinogenesis. Cancer Lett,2003,194(2):199-208.
[12] Morin G B. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats.Cell,1989,59(3):521-529.
[13] Harley C B, Andrews W,Chiu C P,et al.Telomeres shorten during ageing of human fibroblasts. Nature,1990,345(6274): 458-460.
[14] Steinert S, Shay J W, Wright W E.Transient expression of human telomerase extends the lifespan of normal human fibroblasts. Bioehem BioPhys Res Commun,2000,273(3):1095-1098.
[15] Rambhatla L,Chiu C P,Glickman R D,et al. In vitro differentiation capacity of telomerase immortalized human RPE cells.Invest Ophthalmol Vis Sci,2002,43(5):1622-1630.
[16] Ramirez R,Morales C P,Shea-Herbert B,et al.Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions.Gene Dev,2001,15(4):398-403.
[17] Sanders D A.No false start for novel pseudotyped vectors.Curr Opin Biotechnol, 2002,13(5):437-442.
[18] 张磊,刘庆友,胡天,等. 第三代慢病毒高效率包装系统的建立. 基因组学与应用生物学,2009,28(2):326-330. Zhang L,Liu Q Y,Hu T,et al.Genomics and Applied Biology, 2009,28(2):326-330.
[19] Schaetzlein S,Rudolph K L.Telomere length regulation during cloning, embryogenesis and ageing.Reprod Fertil Dev,2005,17(2): 85-96.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|